Under the microscope: NeuroScientific Biopharmaceuticals (ASX:NSB) - Matthew Liddelow, CEO & MD

from Morgans Under the Microscope · host Morgans Financial Limited

Matthew Liddelow, Chief Executive Officer and Managing Director of NeuroScientific Biopharmaceuticals (ASX:NSB) was interviewed by Morgans Senior Analyst Scott Power. Matthew detailed NSB as a company as well as their position heading into the next 12 months.

Episode metadata supplied by the publisher feed · Published Nov 22, 2019

Embed this episode

Attribution link and audio player

NOW PLAYING

Under the microscope: NeuroScientific Biopharmaceuticals (ASX:NSB) - Matthew Liddelow, CEO & MD

0:00 4:21

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Morgans Under the Microscope?

This episode is 4 minutes long.

When was this Morgans Under the Microscope episode published?

This episode was published on November 22, 2019.

Can I download this Morgans Under the Microscope episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!